KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.88 $1.42 Thursday, 25th Apr 2024 BLUE stock ended at $0.91. This is 1.13% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 5.53% from a day low at $0.88 to a day high of $0.93.
90 days $0.88 $1.92
52 weeks $0.88 $5.53

Historical bluebird bio prices

Date Open High Low Close Volume
Mar 20, 2024 $1.40 $1.43 $1.36 $1.40 3 805 441
Mar 19, 2024 $1.44 $1.45 $1.36 $1.40 5 975 994
Mar 18, 2024 $1.45 $1.55 $1.37 $1.44 7 842 012
Mar 15, 2024 $1.33 $1.46 $1.32 $1.42 26 515 769
Mar 14, 2024 $1.39 $1.39 $1.30 $1.33 4 657 221
Mar 13, 2024 $1.33 $1.46 $1.33 $1.39 5 931 173
Mar 12, 2024 $1.48 $1.48 $1.32 $1.35 7 383 273
Mar 11, 2024 $1.61 $1.66 $1.37 $1.39 12 588 439
Mar 08, 2024 $1.45 $1.65 $1.45 $1.50 9 374 768
Mar 07, 2024 $1.47 $1.51 $1.40 $1.45 6 371 523
Mar 06, 2024 $1.43 $1.54 $1.36 $1.45 11 145 933
Mar 05, 2024 $1.43 $1.50 $1.38 $1.39 8 275 718
Mar 04, 2024 $1.63 $1.63 $1.44 $1.53 10 829 213
Mar 01, 2024 $1.41 $1.67 $1.40 $1.57 11 597 786
Feb 29, 2024 $1.68 $1.74 $1.35 $1.39 19 280 971
Feb 28, 2024 $1.80 $1.87 $1.63 $1.68 14 571 174
Feb 27, 2024 $1.52 $1.92 $1.47 $1.75 29 601 622
Feb 26, 2024 $1.29 $1.52 $1.28 $1.46 18 084 311
Feb 23, 2024 $1.22 $1.32 $1.17 $1.25 11 371 798
Feb 22, 2024 $1.06 $1.20 $1.06 $1.18 6 593 255
Feb 21, 2024 $1.08 $1.14 $1.05 $1.09 4 361 462
Feb 20, 2024 $1.04 $1.13 $1.02 $1.10 7 153 310
Feb 16, 2024 $1.07 $1.08 $1.00 $1.02 7 020 587
Feb 15, 2024 $1.04 $1.13 $1.02 $1.08 7 385 655
Feb 14, 2024 $1.01 $1.04 $1.01 $1.03 2 960 115
Click to get the best stock tips daily for free!

About bluebird bio

bluebird bio bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clini... BLUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT